MSB 2.29% $1.28 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-849

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,726 Posts.
    lightbulb Created with Sketch. 5754
    and now the FDA say they think they had what they needed all along.

    In that case (pun intended), the CA lawyers must be in a panic (not that I ever thought they had a valid case in the first place) …. LMAO

    I would rather the BLA resubmission is water tight this time around as I believe we will receive a 2 month PDUFA date so I am ok with it being lodged in late June


    GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.28
Change
-0.030(2.29%)
Mkt cap ! $1.461B
Open High Low Value Volume
$1.32 $1.35 $1.28 $1.677M 1.289M

Buyers (Bids)

No. Vol. Price($)
10 44452 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.29 23596 1
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.